78J-58784-36268
4 vaccinations
1 coded response
51 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 200 / DC
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
Q4R-21165-41362
Child or adolescent in my care · Male · 2022-06-23
Timeline
-
2021-04-12
Registered in v-safe
-
2021-04-12
Dose 1 — Pfizer-BioNTech
- 2021-04-12
- 2021-04-13
-
2021-04-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body achesAdult check-in
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-26
-
2021-05-03
Dose 2 — Pfizer-BioNTech
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-05-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-05-07
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-07
- 2021-06-14
- 2021-08-02
- 2021-11-01
-
2021-12-08
Dose 3 — Pfizer-BioNTech
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-15
- 2021-12-22
- 2021-12-29
- 2022-01-05
- 2022-01-12
- 2022-01-19
- 2022-03-09
-
2022-10-11
Dose 4 — ModernaCo-administered: Flu
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-11-10
- 2022-11-15
- 2022-11-22
- 2023-01-10
-
2023-04-13
Survey response — 6 months, dose 4MedDRA: Malaise, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-04-13
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2023-04-14
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Pfizer-BioNTech | |
| 2 | 2021-05-03 | Pfizer-BioNTech | |
| 3 | 2021-12-08 | Pfizer-BioNTech | No |
| 4 | 2022-10-11 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-13 | Successful 2023-04-14 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Malaise | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release